Guardian and Selective Killer: The Versatile Functions of TLR3 in Hepatocellular Carcinoma

被引：2
|
作者：
Liu, Chen [1 ]
机构：
[1] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2012年 / 104卷 / 23期
关键词：
TOLL-LIKE RECEPTORS; SUPPRESSOR-CELLS; DEFENSE; EVASION; CANCER;
D O I：
10.1093/jnci/djs475
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1780 / 1782
页数：3
相关论文
共 50 条
  • [1] Inhibitory effect of dsRNA TLR3 agonist in a rat hepatocellular carcinoma model
    Xu, Yu-Yin
    Chen, Li
    Zhou, Jia-Ming
    Wu, Yuan-Yuan
    Zhu, Yuan-Yuan
    MOLECULAR MEDICINE REPORTS, 2013, 8 (04) : 1037 - 1042
  • [2] Toll-like receptor 3 (TLR3): a tumor suppressor gene in hepatocellular carcinoma?
    Fares, Nadim
    Bonnin, Marc
    Testoni, Barbara
    Garcia, Amandine
    Vanbervliet, Beatrice
    Lefrancois, Lydie
    Hervieu, Valerie
    Bancel, Brigitte
    Renno, Toufic
    Merle, Philippe
    Lebecque, Serge
    HEPATOLOGY, 2016, 64 : 226A - 226A
  • [3] ACTG1 and TLR3 are biomarkers for alcohol-associated hepatocellular carcinoma
    Gao, Bing
    Li, Shicheng
    Tan, Zhen
    Ma, Leina
    Liu, Jia
    ONCOLOGY LETTERS, 2019, 17 (02) : 1714 - 1722
  • [4] TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis
    Yuan, Ming-Ming
    Xu, Yu-Yin
    Chen, Li
    Li, Xing-Yu
    Qin, Jing
    Shen, Ying
    BMC CANCER, 2015, 15
  • [5] TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis
    Ming-Ming Yuan
    Yu-Yin Xu
    Li Chen
    Xing-Yu Li
    Jing Qin
    Ying Shen
    BMC Cancer, 15
  • [6] TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression
    Ho, Victor
    Lim, Tong Seng
    Lee, Justin
    Steinberg, Jeffrey
    Szmyd, Radoslaw
    Tham, Muly
    Yaligar, Jadegoud
    Kaldis, Philipp
    Abastado, Jean-Pierre
    Chew, Valerie
    ONCOTARGET, 2015, 6 (29) : 27252 - 27266
  • [7] Head and neck cancer triggers the internalization of TLR3 in natural killer cells
    Pries, R.
    Kessetring, R.
    Wulff, S.
    Wollenberg, B.
    ORAL ONCOLOGY, 2007, : 186 - 187
  • [8] Gene polymorphisms of TLR2 and TLR3 in HBV clearance and HBV-related hepatocellular carcinoma in a Chinese male population
    Chen, Dongni
    Xie, Weimin
    Lu, Yongkui
    Su, Shining
    Nong, Li
    Jia, Yuxian
    Liu, Yan
    Zhou, Wenxian
    Wang, Hongxue
    Tan, Aihua
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2017, 32 (02): : E195 - E201
  • [9] TLR3 activation enhances antitumor effects of sorafenib in hepatocellular carcinoma by activating NK cell functions through ERK and NF-κB pathways
    Zhang, Qiang-bo
    Wang, Hong
    Xu, Fei
    Song, Yan
    Jiang, Run-de
    Li, Qi
    Liu, En-yu
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [10] Head and neck cancer triggers the internalization of TLR3 in natural killer cells
    Xie, Lei
    Pries, Ralph
    Kesselring, Rebecca
    Wulff, Sandra
    Wollenberg, Barbara
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2007, 20 (04) : 493 - 499
12345